Literature DB >> 2426261

Purification and biologic properties of fibroblast somatomedin.

D R Clemmons, D S Shaw.   

Abstract

Cultured human fibroblasts produce a peptide growth factor that cross-reacts with antisera to human somatomedin-C (Sm-C). To determine the identity of this species and compare its molecular properties to pure Sm-C, 2 liters of conditioned medium derived from human fibroblast monolayers were concentrated (X10) by ultrafiltration. The concentrated conditioned medium was purified further by CM-Sephadex ion-exchange chromatography. Following elution in 1.0 M NaCl, pH 8.0, the active material was purified by gel filtration on Sephadex G-150. The active fractions which eluted at Kd 0.45 (Mr estimated at 32,000) were further purified by isoelectric focusing. Two peaks of activity electrofocused at pI 5.4 and 7.2, respectively. The pI 5.4 peak contained only binding protein activity. The active fractions from the neutral pool were further purified by reverse-phase high pressure liquid chromatography on a C-18 Bondapak with a linear gradient of acetonitrile (10-60%). The active single peak which eluted at 55% acetonitrile gave a single band when analyzed by polyacrylamide gel electrophoresis. This material stimulated [3H]thymidine incorporation into human fibroblast DNA with approximately 3.2 times the potency of pure Sm-C but was equipotent in stimulating BALB/c 3T3 fibroblasts. It was degraded by fibroblast cultures at a slower rate compared to Sm-C, although it had a similar affinity for Sm-C-binding protein. We conclude that human fibroblasts produce two peptides that react with anti-Sm-C antibody but are chemically distinct from Sm-C. The greater response to fibroblast somatomedin may be due to its affinity for somatomedin-binding protein and slower degradation. These findings may have implications for understanding the regulation of human fibroblast replication.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426261

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Molecular biology of the insulin-like growth factors. Relevance to nervous system function.

Authors:  J E Hepler; P K Lund
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

2.  Insulin-like growth factor (IGF) binding proteins and their mRNAs in connective tissues of fasted guinea-pigs.

Authors:  A Gosiewska; B Peterkofsky
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

3.  Postoperative biosynthetic human growth hormone increases the strength and collagen deposition of experimental colonic anastomoses.

Authors:  H Christensen; H Oxlund; S Laurberg
Journal:  Int J Colorectal Dis       Date:  1991-08       Impact factor: 2.571

Review 4.  Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.

Authors:  P J Verschure; C J Van Noorden; J Van Marle; W B Van den Berg
Journal:  Histochem J       Date:  1996-12

Review 5.  Somatomedins: chemical and functional characteristics of the different molecular forms.

Authors:  A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

6.  Mitogenic effects of growth hormone in cultured human fibroblasts. Evidence for action via local insulin-like growth factor I production.

Authors:  J J Cook; K M Haynes; G A Werther
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

7.  Regulation of insulin-like growth factor I gene expression in the human macrophage-like cell line U937.

Authors:  I Nagaoka; B C Trapnell; R G Crystal
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

8.  Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro.

Authors:  V F Tapson; M Boni-Schnetzler; P F Pilch; D M Center; J S Berman
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

9.  Intestinal subepithelial myofibroblasts in inflammatory bowel diseases.

Authors:  Akira Andoh; Sanae Fujino; Takafumi Okuno; Yoshihide Fujiyama; Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

10.  Alveolar macrophages release an insulin-like growth factor I-type molecule.

Authors:  W N Rom; P Basset; G A Fells; T Nukiwa; B C Trapnell; R G Crysal
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.